|
|
Volumn 8, Issue 12, 2013, Pages
|
|
Effective crizotinib schedule for brain metastases in ALK rearrangement metastatic non-small-cell lung cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
CRIZOTINIB;
DNA;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
PYRAZOLE DERIVATIVE;
PYRIDINE DERIVATIVE;
ADULT;
BRAIN METASTASIS;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
FLUORESCENCE IN SITU HYBRIDIZATION;
FOLLOW UP;
GENE;
HUMAN;
IMMUNOHISTOCHEMISTRY;
INTRON;
LUNG NON SMALL CELL CANCER;
MALE;
METASTATIC NON SMALL CELL LUNG CANCER;
MIDDLE AGED;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RNA EDITING;
SHORT SURVEY;
STAINING;
BRAIN NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
FEMALE;
GENE REARRANGEMENT;
GENETICS;
LUNG NEOPLASMS;
PATHOLOGY;
PROGNOSIS;
SECONDARY;
BRAIN NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
DNA, NEOPLASM;
FEMALE;
GENE REARRANGEMENT;
HUMANS;
IN SITU HYBRIDIZATION, FLUORESCENCE;
LUNG NEOPLASMS;
MIDDLE AGED;
PROGNOSIS;
PROTEIN KINASE INHIBITORS;
PYRAZOLES;
PYRIDINES;
RECEPTOR PROTEIN-TYROSINE KINASES;
|
|
EID: 84892144742
PISSN: 15560864
EISSN: 15561380
Source Type: Journal
DOI: 10.1097/JTO.0000000000000038 Document Type: Article |
|
Times cited : (30)
|
|
References (5)
|
